What are the treatment options for bronchitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bronchitis Treatment

Acute Bronchitis

Antibiotics should NOT be prescribed for acute bronchitis, as viruses cause over 90% of cases and antibiotics provide minimal benefit (reducing cough by only half a day) while causing significant adverse effects. 1, 2, 3, 4

Symptomatic Management

  • Short-acting β-agonists (albuterol) may reduce cough duration and severity in patients with evidence of bronchial hyperresponsiveness 1, 2
  • Ipratropium bromide may improve cough in some patients 1, 2
  • Dextromethorphan or codeine are recommended for short-term symptomatic relief of bothersome cough 1, 2

When to Consider Antibiotics (Rare Exceptions)

  • Patients aged ≥75 years with fever 5
  • Patients with cardiac failure 5
  • When pertussis is suspected to reduce transmission 1, 3

Critical Diagnostic Step

  • Rule out pneumonia by assessing for tachycardia, tachypnea, fever, and abnormal chest examination findings before diagnosing uncomplicated bronchitis 2, 5, 4
  • Chest radiography is usually not indicated in healthy, nonelderly adults without vital sign abnormalities or asymmetrical lung sounds 2

Chronic Bronchitis (Stable)

Smoking cessation is the cornerstone of therapy, with 90% of patients experiencing resolution of cough after quitting. 1, 2

First-Line Bronchodilator Therapy

  • Short-acting β-agonists should be used to control bronchospasm and relieve dyspnea; may also reduce chronic cough 6, 1
  • Ipratropium bromide should be offered to improve cough 6, 1
  • Theophylline should be considered to control chronic cough, but requires careful monitoring for complications 6

Advanced Therapy for Persistent Symptoms

  • Long-acting β-agonists combined with inhaled corticosteroids should be offered to control chronic cough 6, 1
  • Inhaled corticosteroids alone should be offered to patients with FEV1 <50% predicted or those with frequent exacerbations 6, 1, 5

Treatments NOT Recommended

  • Expectorants lack evidence of effectiveness and should not be used 6, 1
  • Postural drainage and chest percussion have not proven beneficial 6
  • Long-term prophylactic antibiotics are not recommended 1

Acute Exacerbations of Chronic Bronchitis (AECB)

Short-acting β-agonists or anticholinergic bronchodilators should be administered immediately; if no prompt response, add the other agent after maximizing the first. 6, 1

Systemic Corticosteroids

  • A short course (10-15 days) of systemic corticosteroids is effective for acute exacerbations 6, 1
  • IV therapy for hospitalized patients and oral therapy for ambulatory patients are both effective 6
  • A 2-week course is equivalent to an 8-week course with fewer side effects 6

Antibiotic Therapy

  • Antibiotics are recommended for acute exacerbations, particularly for patients with severe exacerbations and those with more severe airflow obstruction at baseline 1, 2
  • Reserve antibiotics for patients with at least 2 of 3 cardinal symptoms: increased dyspnea, increased sputum production, increased sputum purulence 7, 8
  • Risk factors warranting antibiotics: age ≥65 years, FEV1 <50% predicted, ≥4 exacerbations in 12 months, or comorbidities 7

Antibiotic Selection

  • Moderate severity: newer macrolide (azithromycin), extended-spectrum cephalosporin, or doxycycline 7
  • Severe exacerbation: high-dose amoxicillin/clavulanate or respiratory fluoroquinolone 9, 7
  • Azithromycin 500 mg once daily for 3 days showed 85% clinical cure rate at Day 21-24 for AECB 10

Treatments NOT Recommended During Exacerbations

  • Theophylline should NOT be used for acute exacerbations 6, 1, 5
  • Expectorants are not effective and should not be used 6, 1
  • Mucokinetic agents are not useful during acute exacerbations 6

Common Pitfalls to Avoid

  • Do not prescribe antibiotics based solely on colored sputum - purulent sputum results from inflammatory cells, not necessarily bacterial infection 2, 5, 3
  • Do not fail to distinguish acute bronchitis from pneumonia - check vital signs and lung examination carefully 2, 5
  • Do not use theophylline for acute exacerbations despite its benefit in stable chronic bronchitis 6, 5
  • Do not underestimate airflow obstruction - routine pulmonary function testing is important as physical exam alone underestimates severity 8

Patient Communication Strategies

  • Set realistic expectations: cough typically lasts 10-14 days after the office visit 5, 4
  • Consider calling the illness a "chest cold" rather than bronchitis to reduce antibiotic expectations 5, 4
  • Explain that patient satisfaction depends more on quality of clinical encounter than receiving antibiotics 5
  • Discuss risks of unnecessary antibiotic use including side effects and antibiotic resistance 5

References

Guideline

Bronchitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Bronchitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and treatment of acute bronchitis.

American family physician, 2010

Research

Acute Bronchitis.

American family physician, 2016

Guideline

Management of Bronchitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Challenging questions in treating bronchitis.

Missouri medicine, 1998

Research

Infectious exacerbations of chronic bronchitis: diagnosis and management.

The Journal of antimicrobial chemotherapy, 1999

Related Questions

What are the treatment options for acute bronchitis?
What is the initial approach to managing bronchitis?
What is the management for a patient with bronchitis, as indicated by bilateral peribronchial thickening on CT (Computed Tomography) chest and spirometry results showing a Forced Expiratory Volume (FEV1)/Forced Vital Capacity (FVC) ratio of 81 percent, with a Forced Vital Capacity (FVC) of 89 percent and Peak Expiratory Flow (PEF) of 49 percent?
What are the treatment options for acute bronchitis?
What are the diagnostic steps and treatment options for bronchitis?
What is the management for an elderly female patient with intermittent epistaxis (nosebleed)?
What is the management for an elderly patient with right hypochondrial pain, dilated gallbladder (GB), and peritoneal nodules, with no stones in the common bile duct (CBD)?
How to manage pain caused by vascular insufficiency?
What is the optimal management plan for a diabetic patient with a history of gallstone disease, presenting with severe right upper quadrant (RUQ) pain, anorexia, jaundice, and general weakness, and found to have a distended gallbladder full of pus with peritoneal nodules on abdominal computed tomography (CT) scan?
Is the diagnosis of Polycystic Ovary Syndrome (PCOS) correct for a 26-year-old female with a history of regular periods, who was on Birth Control (BC) for 1 year and is 9 months post-BC, experiencing amenorrhea, with a history of intense physical activity, normal laboratory results, and an ultrasound showing multiple small follicles?
Why do I keep getting faint positive home pregnancy tests (HPT) followed by negative tests for several months?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.